Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday.
If things go according to plan, the vaccine would be available in the market by the end of this year.
Remdesivir is considered a key anti-viral drug in the fight against Covid-19. In addition, the government has taken three steps to ensure easy access of hospitals and patients to Remdesivir.
Such is the situation of the government in Punjab, the prime minister said while hitting out the Congress, and asserted that he will come to Jalandhar again and pay obeisance at the Devi Talab Mandir.
The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.
Priyanka Gandhi Vadra on Friday promised to restore the old pension scheme for government employees in Himachal Pradesh if the Congress was voted to power in the assembly elections.
The Congress and BJP are apprehensive that AAP might eat into their votes among the Patel community, Kshatriyas, a section of minorities, and Dalits, thus delivering a fatal blow in the closely-contested seats. But the local BJP is elated over the entry of AIMIM as there will be a contender for minority votes apart from the Congress in seats like Bhuj and Mandvi, which have considerable Muslim electorate.
But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das.
He also said the independent media, judiciary, NGOs and dynamic democracy can be misused to destroy the security of a nation.
Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With More drugmakers in line to launch the drug soon, the prices may see a further erosion.
Starting your day with breakfast cereals or granola bars is something diabetic patients should totally avoid.
The seven states are Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal.
A statement issued by the WHO on Saturday said the suspension is in response to the outcomes of its post EUL (emergency use authorisation) inspection held between March 14-22, 2022 and the need to conduct process and facility upgrade to address recently identified GMP (good manufacturing practice) deficiencies.
COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India
Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.
SII is the first indigenous company that has sought emergency approval for the vaccine developed along with global pharma giant AstraZeneca and Oxford University.
Antibody levels are higher when people receive the COVID-19 vaccine in the afternoon as compared to the morning, according to an observational study.
The Directorate of Revenue Intelligence has seized 205.6 kg heroin worth Rs 1,439 crore from a container near Kandla port in Gujarat and arrested an importer from Punjab in this connection following an extensive search operation, the DRI said on Monday.
Prime Minister Narendra Modi is likely to announce a host of initiatives for the health sector on Independence Day with the highlights being the 'Heal in India' and 'Heal by India' projects and a roadmap to eliminate sickle cell disease by 2047, official sources said.
The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.
They agreed to continue technical exchanges to help end the epidemic worldwide as soon as possible, it said.
500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.
The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.
Bharat Biotech is targeting to manufacture one billion doses of its intra-nasal vaccine in 2022 which is under clinical trials now.
'Safety is my first priority.' 'I need to ensure that any drug or vaccine that our citizens get is first safe.'
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
In a setback that could potentially delay the launch of Bharat Biotech's Covid-19 vaccine Covaxin in USA, the Food and Drug Administration there has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation.
The company claims that when the Nitric Oxide Nasal is sprayed over nasal mucosa it acts as a physical and chemical barrier against the virus.
The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date.
Food (ahara) and lifestyle (vihara) have a major impact on the health of your heart.
The US Food and Drug Administration said on Sunday that over 70,000 patients in the country had been treated with convalescent plasma, which is made using the blood of people who have recovered from coronavirus infections.
The present happenings in Manipur are the wages of continued neglect, and not so benign at that, of a vital region and its people. Had we lavished on the North East even a fraction of the care and resources we do on Kashmir, things would not have come to this pass, asserts Shreekant Sambrani.
The third-quarter financials didn't excite market watchers. But equity investors can still make money if they invest in the right stocks.
A day after Punjab Advocate General A P S Deol accused Navjot Singh Sidhu of spreading misinformation and obstructing him, the state Congress chief on Sunday hit back, alleging that the AG's 'earnest inaction' was subverting justice in the sacrilege and drug cases.
The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.
The BJP also promised Rs 25,000 to girls from economically weaker sections under the 'Rani Gaidinliu Nupi Maheiroi Singi Scheme' if voted back to power.
Russia President Vladimir Putin on Monday described India as a great power, a friendly nation and a time-tested friend and echoed common concerns over terrorism, drug trafficking and organised crime as he held wide-ranging talks with Prime Minister Narendra Modi.
India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin COVID-19 vaccine in the age group of 2 to 18 years, the Union Health Ministry said on Thursday.
The researchers from the the University of Texas Health Science Center at San Antonio (UT Health San Antonio) in the United States said by enabling this modification, nsp10 protects the virus from host cell immune response.
Domestic pharma giant Ranbaxy Laboratories Limited has topped the list of patent filers in the area of drug applications from the Third World countries last year with 64 new formulations.\n\n\n\n
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances